Pemetrexed
- Product NDC
- 60505-6066
- 11-digit product format
- 605056066
- Labeler code
- 60505
- Product ID
- 60505-6066_a0cbd788-0c16-e04b-6ff9-3266aa37cef4
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Pemetrexed disodium
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Apotex Corp
- Application
- ANDA203774
- Marketing category
- ANDA
- Marketing start
- 2022-05-25
- Marketing end
- 0000-00-00
- Substance
- PEMETREXED DISODIUM
- Active strength
- 500 mg/20mL
- Pharmacologic classes
- Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 60505-6066 | PEMETREXED (PEMETREXED DISODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [APOTEX CORP] | 5 | Legacy NDC | 20241115_362879e6-92e9-02c7-c420-b787fd887063.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 60505-6066-0 | 60505606600 | 1 VIAL in 1 CARTON (60505-6066-0) > 20 mL in 1 VIAL | 1 vial | 2022-05-25 | 0000-00-00 | No | No | Current |